For over 35 years Sekisui Diagnostics has been committed to providing innovative medical diagnostics to physicians and laboratories. We develop, manufacture, and supply billions of tests each year to the global healthcare market. Our product lines include clinical chemistry and coagulation systems and reagents, point-of-care molecular, rapid tests and immunoassay system as well as enzymes and specialty biochemicals.

BD Veritor ™ System
CLIA-waived for Rapid Detection of Flu A+B meets the New FDA Requirements
Our BD Veritor ™ line of immunoassay products, the BD Veritor ™ Plus System and the BD Veritor ™ System give healthcare providers and laboratorians in near patient settings the objective, lab-quality tests results at the point of care within minutes. This assay system eliminates the subjectivity of visual interpretations of tests results and replaces it with an objective digital result.
BD Veritor ™ System – Proven Performance vs. Polymerase Chain Reaction (PCR)

PCR is currently the highest sensitivity standard
available

Summary of the Performance Data for the BD Veritor System for Rapid Detection of Flu A+B tests compared to PCR for all swabs – all sites
Convenient Workflow
Changing The Way You View Rapid Testing

cobas® Influenza A/B assay
The cobas® Influenza A/B assay is the first CLIA-waived, real-time PCR test to detect Influenza A and B in ~20 minutes. Available
for use in non-traditional testing sites, including ERs, physician offices, pharmacy clinics and other urgent care settings.
Benefits:

Lab-quality performance in the detection and differentiation of Influenza A and Influenza B